VLS Stock Overview
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Vita Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.08 |
| 52 Week High | AU$2.47 |
| 52 Week Low | AU$1.65 |
| Beta | 0.49 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 24.18% |
| 33 Year Change | 22.71% |
| 5 Year Change | 243.80% |
| Change since IPO | 29.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| VLS | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0.5% | -16.4% | 0.9% |
| 1Y | 24.2% | 32.3% | 18.4% |
Return vs Industry: VLS underperformed the Australian Pharmaceuticals industry which returned 32.2% over the past year.
Return vs Market: VLS exceeded the Australian Market which returned 18.4% over the past year.
Price Volatility
| VLS volatility | |
|---|---|
| VLS Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 11.9% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: VLS's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine VLS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | n/a | Andrew O'Keefe | vitalifesciences.com |
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children’s health; antioxidants; bones, joints, and muscles; and eye health.
Vita Life Sciences Limited Fundamentals Summary
| VLS fundamental statistics | |
|---|---|
| Market cap | AU$117.10m |
| Earnings (TTM) | AU$9.39m |
| Revenue (TTM) | AU$79.17m |
12.5x
P/E Ratio1.5x
P/S RatioIs VLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VLS income statement (TTM) | |
|---|---|
| Revenue | AU$79.17m |
| Cost of Revenue | AU$32.77m |
| Gross Profit | AU$46.41m |
| Other Expenses | AU$37.01m |
| Earnings | AU$9.39m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 58.61% |
| Net Profit Margin | 11.86% |
| Debt/Equity Ratio | 0% |
How did VLS perform over the long term?
See historical performance and comparison